Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 1836, March 1, 2009. Published Online First February 24, 2009;
doi: 10.1158/0008-5472.CAN-08-4103
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-4103v1
69/5/1836    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, K.
Right arrow Articles by McConkey, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, K.
Right arrow Articles by McConkey, D. J.

Cell, Tumor, and Stem Cell Biology

Control of HIF-1{alpha} Expression by eIF2{alpha} Phosphorylation–Mediated Translational Repression

Keyi Zhu1,2, WaiKin Chan3, John Heymach1,4, Miles Wilkinson3 and David J. McConkey1,2

Departments of 1 Cancer Biology, 2 Urology, 3 Biochemistry and Molecular Biology and 4 Thoracic/Head and Neck Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: David McConkey, Departments of Urology and Cancer Biology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-8591; Fax: 713-792-8747; E-mail: dmcconke{at}mdanderson.org.

Key Words: Bortezomib • NPI-0052 • HIF-1{alpha} • VEGF • ER stress • prostate cancer

Hypoxia inducible factor 1{alpha} (HIF-1{alpha}) plays a central role in regulating tumor angiogenesis via its effects on vascular endothelial growth factor (VEGF) transcription, and its expression is regulated through proteasome-mediated degradation. Paradoxically, previous studies have shown that proteasome inhibitors (PI) block tumor angiogensis by reducing VEGF expression, but the mechanisms have not been identified. Here, we report that PIs down-regulated HIF-1{alpha} protein levels and blocked HIF-1{alpha} transcriptional activity in human prostate cancer cells. PIs induced phosphorylation of the translation initiation factor 2{alpha} (eIF2{alpha}), which caused general translational repression to inhibit HIF-1{alpha} expression. Furthermore, PIs induced HIF-1{alpha} accumulation in LNCaP-Pro5 cells depleted of eIF2{alpha} via siRNA transfection and in MEFs expressing a phosphorylation-deficient mutant form of eIF2{alpha}. Finally, PIs failed to induce eIF2{alpha} phosphorylation or translational attenuation in DU145 or 253JB-V cells, and, in these cells, PIs promoted HIF-1{alpha} accumulation. Our data established that PIs down-regulated HIF-1{alpha} expression in cells that display activation of the unfolded protein response by stimulating phosphorylation of eIF2{alpha} and inhibiting HIF-1{alpha} translation. [Cancer Res 2009;69(5):1836–43]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.